Zhejiang Disai Biological Technology Co., Ltd., established on 2018-05-25, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Import and export;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Retail;Cosmetics Wholesale;R&D and application of cell technology;Human stem cell technology development and application;Medical Research and Experimental Development;housing lease;property management(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Cosmetic production;medical service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. It offers perfusion decellularization and recellularization technology, as well as organ-derived biological products such as MIROMESH and MIRODERM for soft tissue reinforcement and advanced wound care. The company was founded in 2009 by Doris A. Taylor and Cohen Robert and is headquartered in Eden Prairie, MN.

Fresenius Medical Care is a provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1.89 million individuals worldwide. It has a network of 2,716 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. It offers specialty pharmacy and laboratory services and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Bad Homburg, Frankfurt.

Fresenius Medical Care North America is a hospital and health care company that focuses on providing healthcare services to people with renal and other chronic conditions. It offers dialysis facilities, outpatient cardiac and vascular labs, and urgent care centers. Fresenius Medical Care North America (FMCNA) is one of the largest providers of dialysis products and services. It has raised a record amount of money to support the goals and initiatives of the National Kidney Foundation (NKF) over the course of a two-year partnership. Fresenius Medical Care North America was founded in 1996 by Bill Valle and it is headquartered in Waltham, Massachusetts.

Beijing Eurasian Platinum Technology Co., Ltd., established on 2013-02-21, Business scope includes technical promotion services;Investment Advisory,Business Management Consulting;Undertake exhibition and display activities;Sales of chemical products(Free of Hazardous Chemicals,A class of precursor chemicals),Ι class medical device,IIclass of medical devices,Daily necessities,Stationery;Technology Import and Export,Agent import and export;Professional contractors;Sales of Class III Medical Devices;Production of Class III medical devices(Absorbable fibrous repair membrane for limited periodontal regeneration,Composite resin for caries fillings,Oral Restoration Fiber Post).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III Medical Devices,Production of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Huaxia Printing (Shanghai) Biotechnology Co., Ltd., established on 2018-07-27, Business scope includes general items:3DTechnology development in the field of printing technology,technical consulting,technology transfer,Technical Services;3DProduction of printing equipment;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Manufacturing of bio-based materials;Sales of bio-based materials;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);R&D and application of cell technology;Engineering and Technology Research and Experimental Development;housing lease;Non-residential real estate leases;Machinery and Equipment Leasing;Medical equipment rental.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Import and export;Technology Import and Export;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Manufactures and sells pharmaceuticals

Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. Its products include cordycepin, metallothionein, marine elements, embryonic nutrients, and active compound of antodia cinnamomea. The company was founded on September 24, 2014 and is headquartered in Fishers, IN.

Part of Hämäläinen & Karjalainen Oy, Faktor Oy is a Finnish company located in Helsinki. The firm specializes in prepress production and the improvement of production processes. It was acquired by Hämäläinen & Karjalainen Oy from Talentum Oy on November 28, 2008.

Isu Abxis provides value-added treatment methods based on biotechnology to improve the quality of life of refractory patients suffering from cancer and rare diseases , provide members with opportunities for self-realization, They are constantly striving to become a company that can contribute to society through management .

Odontis is developing a biological replacement tooth product - the BioToothTM.\nThe research is lead by Professor Paul Sharpe at King's College London Dental Institute. His team has demonstrated that tooth development can be initiated in stem cells, and that fully formed teeth can be created in developmental models. This is pioneering in that it represents one of the very few examples of a fully integrated tissue engineered organ.\nThe technology opens the potential for the implantation of cultured cells in patients to grow and replace damaged or missing teeth.\nOdontis has attracted over £2 million of funding to date to progress the technology to commercial development.

INSERM Transfert SA is a Venture Capital firm, a subsidiary of Institut National de la Sant? et de la Recherche M?dicale founded in 2000. INSERM Transfert SA is headquartered in Paris, France.

NeuroProof GmbH provides screening services for pre-clinical development of neuro-pharmaceuticals. It offers phenotypic profiling, cell viability and cytotoxicity, target validation, combination and adjunctive, and data analysis. The company was founded by Olaf Schr��der, Alexandra Vo��, and Dieter G. Weiss in 2007 and is headquartered in Rostock, Germany.

Golden Page Biotechnology (Nanjing) Co., Ltd., established on 2019-05-28, Business scope includes biotechnology,Technology development in the field of medical science and technology,technical consulting,Technical Services,technology transfer;Drug development and production(Limited to branch operations);Business Management Consulting;Sales of laboratory equipment and consumables.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Everwin Precision Technology Co., Ltd. engages in the research, development, production, and sale of precision electronic components. It offers electronic connector parts, smart electronic product components, new energy vehicle connectors and modules, consumer electronics precision structural parts and modules, and robotics and industrial networks. The company was founded on July 17, 2001 and is headquartered in Shenzhen, China.

Theradigm develops stem-cell-based therapies to treat diseases of the central nervous system. Building upon promising pre-clinical data, Theradigm is initially pursuing treatments for stroke and spinal cord injury. Other treatments under development will address traumatic brain injury. Theradigm's stem cells are used to provide trophic support, and potentially to rescue or replace injured tissue in the central nervous system.

Hunan Aoxing Biomedical Co., Ltd., established on 2013-09-22, The scope of business includes the manufacture of sanitary materials and medical supplies;Development of Bone Filling Adhesives,Production,Sales;Research and development of biomedical technology,technical consulting,technology transfer;Medical Device Sales;medicine,Chinese patent medicine,Chinese herbal medicine,food,Health products,Biological product,beauty products,R&D of cosmetics,production and sales;Information consultation and service(Does not include finance,securities,futures,Investment and financing information);Medical Supplies,Development and sales of laboratory preparations;Technology import and export and agency sales of imported products(Except for import and export commodities and technologies that are restricted or prohibited by the state);Gene Technology and Testing;Development and construction of e-commerce platform.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments;Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)